CASP3 and myeloid leukemia: Combined treatment with quercetin and cisplatin synergistically reduced ATP levels and increased caspase 3 activity in all lymphoid and myeloid leukaemia cell lines (Supplementary Figures 2 and 3), shown here in Jurkat and THP-1 cells (Figures 1 and 2).